Products

Cover My Assets

We're Not for Corporate America

cover-my-assets.com TelegramLegal & Compliance / IP & Brand Protection

Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
$49/mo
Higher than 64% of peersNiche median $19.49/mo
Creators
Cover My Assets
@cma_bianca· 21 followers
Launched
8mo ago
2026-04-06 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    Privacy & legal complaince tools for adult creators

    Apr 6 · 8mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2025-03-18

KeywordMonthly volume
ceartas1,100
collab definition40

Traffic data: Vaneform

Pricing

Side Hustle
$49/mo
Boss Babe
$89/mo
Queen B
$119/mo

Trial: None · 3 paid tiers ($49–$119) · Observed 2026-11-07 · Pricing page

Entry price $49/mo, Higher than 64% of peers; “IP & Brand Protection” median is $19.49/mo.View pricing benchmark

Website snapshots

Indexed 2026-04-06

Key pages

Desktop & mobile archive
cover-my-assets.com/ Snapshot 2026-11-07

Questions & evidence

How much does Cover My Assets cost?
Side Hustle: $49/mo; Boss Babe: $89/mo; Queen B: $119/mo. Observed 2026-11-07. Check the source for current billing terms, usage limits and taxes.Source
How much website traffic does Cover My Assets get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Cover My Assets and what platforms does it support?
Cover My Assets is catalogued under IP & Brand Protection: We're Not for Corporate America. Supported platforms: Web.

Related products in this category

Legal & Compliance / IP & Brand Protection

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.